1. Home
  2. CMND vs SILO Comparison

CMND vs SILO Comparison

Compare CMND & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • SILO
  • Stock Information
  • Founded
  • CMND 2017
  • SILO 2010
  • Country
  • CMND Canada
  • SILO United States
  • Employees
  • CMND N/A
  • SILO N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • SILO Apparel
  • Sector
  • CMND Health Care
  • SILO Consumer Discretionary
  • Exchange
  • CMND Nasdaq
  • SILO Nasdaq
  • Market Cap
  • CMND 4.8M
  • SILO 4.5M
  • IPO Year
  • CMND N/A
  • SILO N/A
  • Fundamental
  • Price
  • CMND $0.99
  • SILO $0.58
  • Analyst Decision
  • CMND
  • SILO
  • Analyst Count
  • CMND 0
  • SILO 0
  • Target Price
  • CMND N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • CMND 2.2M
  • SILO 321.4K
  • Earning Date
  • CMND 06-12-2025
  • SILO 08-12-2025
  • Dividend Yield
  • CMND N/A
  • SILO N/A
  • EPS Growth
  • CMND N/A
  • SILO N/A
  • EPS
  • CMND N/A
  • SILO N/A
  • Revenue
  • CMND N/A
  • SILO $72,102.00
  • Revenue This Year
  • CMND N/A
  • SILO $1.86
  • Revenue Next Year
  • CMND N/A
  • SILO N/A
  • P/E Ratio
  • CMND N/A
  • SILO N/A
  • Revenue Growth
  • CMND N/A
  • SILO N/A
  • 52 Week Low
  • CMND $0.80
  • SILO $0.41
  • 52 Week High
  • CMND $2.30
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • CMND 55.23
  • SILO 44.04
  • Support Level
  • CMND $0.94
  • SILO $0.60
  • Resistance Level
  • CMND $1.05
  • SILO $0.64
  • Average True Range (ATR)
  • CMND 0.08
  • SILO 0.04
  • MACD
  • CMND 0.02
  • SILO 0.00
  • Stochastic Oscillator
  • CMND 34.38
  • SILO 2.48

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: